A Study of GFH312 in Healthy Subjects

Clinical trial NCT04676711 · COMPLETED

Trial details

NCT number: NCT04676711
Sponsor: GenFleet Therapeutics (Australia) Pty Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Toxicity Healthy

Start date: 2021-04-27
Primary completion: 2022-05-23
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.